Skip to main content
Fig. 2 | Antimicrobial Resistance & Infection Control

Fig. 2

From: Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018

Fig. 2

Anti-tuberculosis drug resistance profile of patients with rifampicin resistant tuberculosis, N = 642, Uganda 2014–2018. INH, Isoniazid; RMP, Rifampicin; SM, Streptomycin; EMB, Ethambutol; PZ, Pyrazinamide; KAN, Kanamycin; LEV, Levofloxacin; MOX, Moxifloxacin; OFL, Ofloxacin; CAP, Capreomycin; AMK, Amikacin

Back to article page